Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Protagenic Therapeutics (PTIX)
NASDAQ:PTIX
Protagenic Therapeutics (PTIX) Ownership - Who Owns Protagenic Therapeutics?
24 Followers
Protagenic Therapeutics (PTIX) Ownership Overview
10.24% Insiders
1.28% Mutual Funds
10.56% Other Institutional Investors
77.92% Public Companies and
Individual Investors
The ownership structure of Protagenic Therapeutics (PTIX) stock is a mix of institutional, retail and individual investors. Approximately 11.84% of the company’s stock is owned by Institutional Investors, 10.24% is owned by Insiders and 77.92% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 13, 2023 | xxxxxxxxxxxxx | $6480 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 31,996 | Institution | 0.72% | 24,765 | |
| 31,996 | Institution | 0.72% | 24,765 | |
| 25,123 | Institution | 0.56% | 19,445 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 31,996 | Institution | 0.72% | 24,765 | |
| 25,123 | Institution | 0.56% | 19,445 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 31,996 | Institution | 0.72% | 42,235 |
FAQ
Who Owns Protagenic Therapeutics (PTIX)?
According to the latest TipRanks data, approximately 10.56% of the company's stock is held by institutional investors, 10.24% is held by insiders, and 77.92% is held by retail investors.
What percentage of Protagenic Therapeutics (PTIX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 10.56% of Protagenic Therapeutics (PTIX) stock is held by institutional investors.
What percentage of Protagenic Therapeutics (PTIX) stock is held by retail investors?
According to the latest TipRanks data, approximately 77.92% of Protagenic Therapeutics (PTIX) stock is held by retail investors.
Who owns the most shares of Protagenic Therapeutics (PTIX)?
Vanguard owns the most shares of Protagenic Therapeutics (PTIX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.